npj Genomic Medicine (Dec 2024)

Analysis of exonic deletions in a large population study provides novel insights into NRXN1 pathology

  • Simone Montalbano,
  • Morten Dybdahl Krebs,
  • Anders Rosengren,
  • Morteza Vaez,
  • Kajsa-Lotta Georgii Hellberg,
  • Preben B. Mortensen,
  • Anders D. Børglum,
  • Daniel H. Geschwind,
  • iPSYCH Investigators,
  • Armin Raznahan,
  • Wesley K. Thompson,
  • Dorte Helenius,
  • Thomas Werge,
  • Andrés Ingason

DOI
https://doi.org/10.1038/s41525-024-00450-8
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 10

Abstract

Read online

Abstract The NRXN1 locus is a hotspot for non-recurrent copy number variants and exon-disrupting NRXN1 deletions have been associated with increased risk of neurodevelopmental disorders in case-control studies. However, corresponding population-based estimates of prevalence and disease-associated risk are currently lacking. Also, most studies have not differentiated between deletions affecting exons of different NRXN1 splice variants nor considered intronic deletions. We used the iPSYCH2015 case-cohort sample to obtain unbiased estimates of the prevalence of NRXN1 deletions and their associated risk of autism, schizophrenia, depression, and ADHD. Most exon-disrupting deletions affected exons specific to the alpha isoform, and almost half of the non-exonic deletions represented a previously reported segregating founder deletion. Carriage of exon-disrupting NRXN1 deletions was associated with a threefold and twofold increased risk of autism and ADHD, respectively, whereas no significantly increased risk of depression or schizophrenia was observed. Our results highlight the importance of using population-based samples in genetic association studies.